Conditions: Allergic Conjunctivitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 60
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the efficacy and safety of an anti-allergy eyedrop.

Detailed description:

Arms:
arm 1: active treatment: administered as a single one-drop dose in each eye at each visit (Day 0 and Day 14). arm 2: Placebo, vehicle: administered as a single one-drop dose in each eye at each visit (Day 0 and Day 14).

Interventions: intervention 1: alcaftadine intervention 2: Placebo
Intervention descriptions: intervention 1: 0.25% Ophthalmic Solution, one drop in each eye at each of two visits. intervention 2: Vehicle without active, one drop in each eye at each of two visits.

Protocol document: